vimarsana.com
Home
Live Updates
Division of Rheumatology Leads Partnership to Study Pathways in Autoimmune and Immune-Mediated Diseases (AIM) : vimarsana.com
Division of Rheumatology Leads Partnership to Study Pathways in Autoimmune and Immune-Mediated Diseases (AIM)
/PRNewswire/ -- NYU Langone Health is joining a new National Institutes of Health (NIH)-sponsored program called Accelerating Medicines Partnership Autoimmune...
Related Keywords
California ,
United States ,
Michigan ,
San Francisco ,
Joseu Scher ,
Ryan Dziuba ,
Steven Abramson ,
Caroline Shiboski ,
Jill Buyon ,
Peterm Izmirly ,
Medicines Partnership Autoimmune ,
Johns Hopkins University ,
University Of California ,
Lupus Research ,
Langone Health ,
Teach Microbiome Technology ,
Ohio State University ,
University Of Texas South ,
University Of Michigan ,
Team For Accelerating Medicines Partnership ,
University Of Rochester ,
Langone Division Of Rheumatology ,
Clemente Lab ,
Department Of Medicine ,
Division Of Rheumatology ,
Analytic Center Hub ,
Lupus Omics Cutaneous Kidney Investigation Team ,
Albert Einstein College Of Medicine ,
National Institutes Of Health ,
Drug Administration ,
Icahn School Of Medicine At Mount Sinai ,
University Of Pennsylvania ,
National Institutes ,
Accelerating Medicines Partnership Autoimmune ,
Immune Mediated Diseases ,
Sir Deryck ,
Lady Va Maughan Professor ,
Steere Abramson Associate Professor ,
Albert Einstein College ,
Texas South ,
Microbiome Technology ,
Icahn School ,
Psoriatic Skin ,
Systems Biology ,
Accelerating Medicines Partnership ,
Nyu Langone Health ,
vimarsana.com © 2020. All Rights Reserved.